These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16198516)

  • 21. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles.
    Cohen LS; Soares CN; Vitonis AF; Otto MW; Harlow BL
    Arch Gen Psychiatry; 2006 Apr; 63(4):385-90. PubMed ID: 16585467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Menopausal hormone therapy (HT) in patients with breast cancer.
    Batur P; Blixen CE; Moore HC; Thacker HL; Xu M
    Maturitas; 2006 Jan; 53(2):123-32. PubMed ID: 16368466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unopposed estrogen therapy and the risk of invasive breast cancer.
    Chen WY; Manson JE; Hankinson SE; Rosner B; Holmes MD; Willett WC; Colditz GA
    Arch Intern Med; 2006 May; 166(9):1027-32. PubMed ID: 16682578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
    Grodstein F; Manson JE; Stampfer MJ
    J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symptoms in the menopausal transition: hormone and behavioral correlates.
    Freeman EW; Sammel MD; Lin H; Gracia CR; Kapoor S
    Obstet Gynecol; 2008 Jan; 111(1):127-36. PubMed ID: 18165401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune effects of surgical menopause and estrogen replacement therapy in peri-menopausal women.
    Kumru S; Godekmerdan A; Yilmaz B
    J Reprod Immunol; 2004 Aug; 63(1):31-8. PubMed ID: 15284002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women.
    Costenbader KH; Feskanich D; Stampfer MJ; Karlson EW
    Arthritis Rheum; 2007 Apr; 56(4):1251-62. PubMed ID: 17393454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Profile of menopausal women in west Anatolian rural region sample.
    Discigil G; Gemalmaz A; Tekin N; Basak O
    Maturitas; 2006 Oct; 55(3):247-54. PubMed ID: 16675168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations between the use of complementary and alternative medications and demographic, health and lifestyle factors in mid-life Australian women.
    Gollschewski S; Anderson D; Skerman H; Lyons-Wall P
    Climacteric; 2005 Sep; 8(3):271-8. PubMed ID: 16390759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone therapy and breast cancer: what factors modify the association?
    Gertig DM; Fletcher AS; English DR; Macinnis RJ; Hopper JL; Giles GG
    Menopause; 2006; 13(2):178-84. PubMed ID: 16645531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormonal and reproductive factors and the risk of bladder cancer in women.
    McGrath M; Michaud DS; De Vivo I
    Am J Epidemiol; 2006 Feb; 163(3):236-44. PubMed ID: 16319290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical versus natural menopause: cognitive issues.
    Henderson VW; Sherwin BB
    Menopause; 2007; 14(3 Pt 2):572-9. PubMed ID: 17476147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Symptoms associated with menopausal transition and reproductive hormones in midlife women.
    Freeman EW; Sammel MD; Lin H; Gracia CR; Pien GW; Nelson DB; Sheng L
    Obstet Gynecol; 2007 Aug; 110(2 Pt 1):230-40. PubMed ID: 17666595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Past oral contraceptive and hormone therapy use and endogenous hormone concentrations in postmenopausal women.
    Chan MF; Dowsett M; Folkerd E; Wareham N; Luben R; Welch A; Bingham S; Khaw KT
    Menopause; 2008; 15(2):332-9. PubMed ID: 17667152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Menstrual and reproductive risk factors and risk for gastric adenocarcinoma in women: findings from the canadian national enhanced cancer surveillance system.
    Frise S; Kreiger N; Gallinger S; Tomlinson G; Cotterchio M
    Ann Epidemiol; 2006 Dec; 16(12):908-16. PubMed ID: 16843679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do breast cancer risk factors modify the association between hormone therapy and mammographic breast density? (United States).
    Aiello EJ; Buist DS; White E
    Cancer Causes Control; 2006 Dec; 17(10):1227-35. PubMed ID: 17111253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
    Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA
    Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type and duration of exogenous hormone use affects breast cancer histology.
    Kumar AS; Cureton E; Shim V; Sakata T; Moore DH; Benz CC; Esserman LJ; Hwang ES
    Ann Surg Oncol; 2007 Feb; 14(2):695-703. PubMed ID: 17103262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.